NASDAQ
Calidi Biotherapeutics, Inc. (CLDI) has a fcf yield of -425.42% as of Monday, August 3, 2026. This represents a 397.30% decrease compared to its 12-month average of -85.55%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.